Select B2i Digital Featured Companies in the News:
- Unicycive Therapeutics (Nasdaq: UNCY) announced upcoming presentations on pipeline candidate UNI-494 at a major kidney disease conference, including efficacy data in animal models and their Phase 1 trial plans.